These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 27340247)

  • 1. Recruitment Into a Pediatric Continuous Glucose Monitoring RCT.
    Volkening LK; Gaffney KC; Katz ML; Laffel LM
    J Diabetes Sci Technol; 2017 Jan; 11(1):100-107. PubMed ID: 27340247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lessons learned from a pilot RCT of simultaneous versus delayed initiation of continuous glucose monitoring in children and adolescents with type 1 diabetes starting insulin pump therapy.
    Olivier P; Lawson ML; Huot C; Richardson C; Nakhla M; Romain J
    J Diabetes Sci Technol; 2014 May; 8(3):523-8. PubMed ID: 24876616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The JDRF CCTN CGM TIME Trial: Timing of Initiation of continuous glucose Monitoring in Established pediatric type 1 diabetes: study protocol, recruitment and baseline characteristics.
    Lawson ML; Bradley B; McAssey K; Clarson C; Kirsch SE; Mahmud FH; Curtis JR; Richardson C; Courtney J; Cooper T; Downie CJ; Rajamannar G; Barrowman N; ;
    BMC Pediatr; 2014 Jul; 14():183. PubMed ID: 25034216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous glucose monitoring systems for type 1 diabetes mellitus.
    Langendam M; Luijf YM; Hooft L; Devries JH; Mudde AH; Scholten RJ
    Cochrane Database Syst Rev; 2012 Jan; 1(1):CD008101. PubMed ID: 22258980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Motivational Stage at Continuous Glucose Monitoring (CGM) Initiation in Pediatric Type 1 Diabetes Is Associated With Current Glycemic Control but Does Not Predict Future CGM Adherence or Glycemic Control.
    Verbeeten KC; Chan J; Sourial N; Courtney JM; Bradley BJ; McAssey K; Clarson C; Kirsch S; Curtis JR; Mahmud FH; Cooper T; Richardson C; Lawson ML; ;
    Can J Diabetes; 2021 Jul; 45(5):466-472.e4. PubMed ID: 34176610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salient characteristics of youth with type 1 diabetes initiating continuous glucose monitoring.
    Telo GH; Volkening LK; Butler DA; Laffel LM
    Diabetes Technol Ther; 2015 Jun; 17(6):373-8. PubMed ID: 25749206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Timing of CGM initiation in pediatric diabetes: The CGM TIME Trial.
    Lawson ML; Verbeeten KC; Courtney JM; Bradley BJ; McAssey K; Clarson C; Kirsch S; Curtis JR; Mahmud FH; Richardson C; Cooper T; Chan J; Tang K
    Pediatr Diabetes; 2021 Mar; 22(2):279-287. PubMed ID: 33098212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment recommendations following 3-day masked continuous glucose monitoring (CGM) in youth with type 1 diabetes.
    Rasbach LE; Atkins AE; Milaszewski KM; Keady J; Schmidt LM; Volkening LK; Laffel LM
    J Diabetes Sci Technol; 2014 May; 8(3):494-7. PubMed ID: 24876612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous Glucose Monitoring Adherence: Lessons From a Clinical Trial to Predict Outpatient Behavior.
    de Bock M; Cooper M; Retterath A; Nicholas J; Ly T; Jones T; Davis E
    J Diabetes Sci Technol; 2016 May; 10(3):627-32. PubMed ID: 26908570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fear of hypoglycemia in children with type 1 diabetes and their parents: Effect of pump therapy and continuous glucose monitoring with option of low glucose suspend in the CGM TIME trial.
    Verbeeten KC; Perez Trejo ME; Tang K; Chan J; Courtney JM; Bradley BJ; McAssey K; Clarson C; Kirsch S; Curtis JR; Mahmud FH; Richardson C; Cooper T; Lawson ML;
    Pediatr Diabetes; 2021 Mar; 22(2):288-293. PubMed ID: 33179818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients' and caregivers' experiences of using continuous glucose monitoring to support diabetes self-management: qualitative study.
    Lawton J; Blackburn M; Allen J; Campbell F; Elleri D; Leelarathna L; Rankin D; Tauschmann M; Thabit H; Hovorka R
    BMC Endocr Disord; 2018 Feb; 18(1):12. PubMed ID: 29458348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Achieving Time in Range Clinical Targets With Treatment Modality Among Youths With Type 1 Diabetes.
    Dovc K; Lanzinger S; Cardona-Hernandez R; Tauschmann M; Marigliano M; Cherubini V; Preikša R; Schierloh U; Clapin H; AlJaser F; Pelicand J; Shukla R; Biester T
    JAMA Netw Open; 2023 Feb; 6(2):e230077. PubMed ID: 36808243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.
    Riemsma R; Corro Ramos I; Birnie R; Büyükkaramikli N; Armstrong N; Ryder S; Duffy S; Worthy G; Al M; Severens J; Kleijnen J
    Health Technol Assess; 2016 Feb; 20(17):v-xxxi, 1-251. PubMed ID: 26933827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Youth and parent measures of self-efficacy for continuous glucose monitoring: survey psychometric properties.
    Rasbach LE; Volkening LK; Markowitz JT; Butler DA; Katz ML; Laffel LM
    Diabetes Technol Ther; 2015 May; 17(5):327-34. PubMed ID: 25695341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes.
    Karter AJ; Parker MM; Moffet HH; Gilliam LK; Dlott R
    JAMA; 2021 Jun; 325(22):2273-2284. PubMed ID: 34077502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous glucose monitoring and glycemic control among youth with type 1 diabetes: International comparison from the T1D Exchange and DPV Initiative.
    DeSalvo DJ; Miller KM; Hermann JM; Maahs DM; Hofer SE; Clements MA; Lilienthal E; Sherr JL; Tauschmann M; Holl RW;
    Pediatr Diabetes; 2018 Nov; 19(7):1271-1275. PubMed ID: 29923262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Techniques of monitoring blood glucose during pregnancy for women with pre-existing diabetes.
    Jones LV; Ray A; Moy FM; Buckley BS
    Cochrane Database Syst Rev; 2019 May; 5(5):CD009613. PubMed ID: 31120549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychological Reactions Associated With Continuous Glucose Monitoring in Youth.
    Patton SR; Clements MA
    J Diabetes Sci Technol; 2016 May; 10(3):656-61. PubMed ID: 26969141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial.
    van Beers CA; DeVries JH; Kleijer SJ; Smits MM; Geelhoed-Duijvestijn PH; Kramer MH; Diamant M; Snoek FJ; Serné EH
    Lancet Diabetes Endocrinol; 2016 Nov; 4(11):893-902. PubMed ID: 27641781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.